Nurse Practitioner, Family · Shelton, CT
NPI
1588150643
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
8
Medicare group memberships
Hospitals
5
Hospital affiliations
110 Commerce Dr
Shelton, CT, 06484
Phone (203) 929-7331
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
186 services
Medicare patients, 2024
94
Average age 66
Drug cost, 2024
$523K
1,394 prescriptions
Company payments, 2025
$68.34
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sarah Knauf was code 99214 (office e&m - established), 81 times for 53 patients. In total Sarah Knauf billed 186 services in 9 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 81 | 53 | $88.21 | $7,145 |
| 99213 Office E&M - Established | Office | 76 | 53 | $61.34 | $4,662 |
By year: 2022 $23K for 332 services; 2023 $20K for 333 services; 2024 $14K for 186 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sarah Knauf prescribed most often to Medicare patients was Motegrity (Prucalopride Succinate), with 213 prescriptions and refills. In total Sarah Knauf wrote 1,394 Medicare prescriptions that cost $523K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Motegrity Prucalopride Succinate | 213 | 358 | 64 | $192K |
| Famotidine Generic | 110 | 211 | 24 | $1,850 |
| Azithromycin Generic | 97 | 191 | 34 | $1,637 |
| Dexlansoprazole Dr Dexlansoprazole | 95 | 178 | 20 | $22K |
| Linzess Linaclotide | 91 | 177 | 27 | $92K |
| Cyproheptadine Hcl Generic | 77 | 144 | 29 | $1,316 |
| Omeprazole Generic | 53 | 118 | 19 | $1,144 |
| Amitriptyline Hcl Generic | 47 | 84 | 13 | $403 |
| Ondansetron Odt Ondansetron | 46 | 50 | 19 | $820 |
| Dexilant Dexlansoprazole | 35 | 63 | Under 11 | $19K |
| Sucralfate Generic | 32 | 32 | Under 11 | $1,922 |
| Pantoprazole Sodium Generic | 32 | 96 | 13 | $586 |
| Dicyclomine Hcl Generic | 30 | 30 | Under 11 | $338 |
| Metronidazole Generic | 29 | 29 | 14 | $191 |
| Xifaxan Rifaximin | 28 | 28 | 25 | $65K |
Brand drugs: 470 claims; generic drugs: 924 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sarah Knauf $68.34 ($68.34 in general payments such as food, travel and fees) from 2 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $44.65.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.